Routine governance filing — no immediate trading catalyst. Monitor for any R&D pipeline implications from the CSO role elimination, though the transition suggests continuity through year-end 2026.
Price Chart
Executive Summary
Indivior eliminated the Chief Scientific Officer position effective June 1, 2026, with Dr. Christian Heidbreder transitioning to an advisory role through year-end 2026 before termination without cause. The company also held its annual shareholder meeting, re-electing all eight director nominees and approving say-on-pay and auditor ratification with strong support. The CSO role elimination is a routine organizational change with no material financial impact disclosed.
Key Facts
- Chief Scientific Officer position eliminated effective June 1, 2026
- Dr. Christian Heidbreder will serve in advisory capacity through December 31, 2026, then terminated without cause
- All eight director nominees re-elected at May 13, 2026 annual meeting
- Say-on-pay approved with 90,364,566 votes for vs 1,324,996 against
- Shareholders voted for annual say-on-pay frequency (91,848,954 votes for 1 year)
- PricewaterhouseCoopers ratified as auditor for FY2026 with 99,146,241 votes for
- 121,922,058 shares entitled to vote; 100,407,722 present at meeting
Financial Impact
No financial impact disclosed; CSO position elimination may yield modest cost savings but not quantified
Risk Factors
- CSO departure could signal reduced R&D prioritization or pipeline shift
- No successor named for CSO role — potential gap in scientific leadership
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001625297-26-000024 |
| Document: 0001625297-26-000024-index-headers.html | 0001625297-26-000024 |
| Document: 0001625297-26-000024-index.html | 0001625297-26-000024 |
| Document: 0001625297-26-000024.txt | 0001625297-26-000024 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | EFFECT | $34.47 $35.53 | ▲ +3.08% | ▲ +2.97% | $35.71 (+3.60%) |
Aug 28, 2026 4w ago | S-4 | $34.93 $34.32 | ▼ −1.75% | ▼ −1.60% | $35.71 (+2.23%) |
Aug 3, 2026 8w ago | 425 / 8-K | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Aug 3, 2026 8w ago | 425 | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Aug 3, 2026 8w ago | 8-K | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Aug 3, 2026 8w ago | 425 / 8-K | $37.37 $38.47 | ▲ +2.94% | ▲ +0.92% | $35.71 (−4.44%) |
Jul 23, 2026 10w ago | Press Release | $40.51 $40.22 | ▼ −0.72% | ▼ −1.19% | $35.71 (−11.85%) |
Jun 12, 2026 16w ago | Insider Cluster | $38.40 $38.32 | ▼ −0.21% | ▲ +1.17% | $35.71 (−7.01%) |
May 15, 2026 20w ago | 8-K | $36.54 $37.81 | ▲ +3.48% | ▲ +1.86% | $35.71 (−2.27%) |
May 4, 2026 21w ago | 8-K | $38.98 $38.84 | ▼ −0.36% | ▼ −3.30% | $35.71 (−8.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access